latest-news-headlines Market Intelligence /marketintelligence/en/news-insights/latest-news-headlines/general-inception-buys-enable-medicine-energy-capital-acquires-atlantica-86777849 content esgSubNav
In This List

General Inception buys Enable Medicine; Energy Capital acquires Atlantica

Blog

Banking Essentials Newsletter: September 18th Edition

Loan Platforms: Securing settlement instructions and prioritising the user experience

Blog

Navigating the New Canadian Derivatives Landscape: Key Changes and Compliance Steps for 2025

Blog

Major Copper Discoveries


General Inception buys Enable Medicine; Energy Capital acquires Atlantica

Click here to participate in the 2025 Private Equity and Venture Capital Outlook Survey to gain insights into private market sentiment for the upcoming year from global private equity, venture capital and limited partner professionals.

_______________________________________________________

Deal Wrap is updated as of 3 p.m. ET.

– General Inception LLC acquired Enable Medicine Inc., a company that organizes biological data and makes it searchable to generate new insights into health and disease.

– A vehicle controlled by funds managed or advised by Energy Capital Partners LLC and that includes a large group of institutional co-investors acquired Atlantica Sustainable Infrastructure PLC. Sellers included Algonquin Power & Utilities Corp., which had a 42.2% equity interest in Atlantica. J.P. Morgan Securities LLC served as the exclusive financial adviser and Weil Gotshal & Manges LLP acted as legal adviser to Algonquin Power in connection with the transaction.

– Cofounders Capital-backed Pattern Health Technologies Inc., a provider of patient engagement, clinical trial and clinical outcome assessment solutions, merged with Greenlight Health Data Solutions Inc.

– Main Capital Partners BV acquired a majority stake in Dutch talent management firm TMA BV.

– Visus Therapeutics Inc., a pharmaceutical company backed by EQT Life Sciences and Johnson & Johnson Innovation - JJDC Inc., merged with Tenpoint Therapeutics Ltd.

For more private equity deals, read our latest In Play report, which looks at potential private equity-backed M&A, including rumored transactions, each week.